DK2877156T3 - Chondroitinkomplekser til transkutan absorption - Google Patents

Chondroitinkomplekser til transkutan absorption Download PDF

Info

Publication number
DK2877156T3
DK2877156T3 DK13747807.9T DK13747807T DK2877156T3 DK 2877156 T3 DK2877156 T3 DK 2877156T3 DK 13747807 T DK13747807 T DK 13747807T DK 2877156 T3 DK2877156 T3 DK 2877156T3
Authority
DK
Denmark
Prior art keywords
transcutan
absorption
chondroitin
complex
chondroitin complex
Prior art date
Application number
DK13747807.9T
Other languages
English (en)
Inventor
Rosa Mario De
Chiara Schiraldi
Original Assignee
Altergon Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altergon Sa filed Critical Altergon Sa
Application granted granted Critical
Publication of DK2877156T3 publication Critical patent/DK2877156T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • A61K8/735Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/54Polymers characterized by specific structures/properties

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Birds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK13747807.9T 2012-07-27 2013-07-25 Chondroitinkomplekser til transkutan absorption DK2877156T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT001316A ITMI20121316A1 (it) 2012-07-27 2012-07-27 Complessi di condroitina ad assorbimento transcutaneo
PCT/EP2013/065733 WO2014016380A1 (en) 2012-07-27 2013-07-25 Chondroitin complexes for transcutaneous absorption

Publications (1)

Publication Number Publication Date
DK2877156T3 true DK2877156T3 (da) 2020-03-02

Family

ID=46939794

Family Applications (1)

Application Number Title Priority Date Filing Date
DK13747807.9T DK2877156T3 (da) 2012-07-27 2013-07-25 Chondroitinkomplekser til transkutan absorption

Country Status (13)

Country Link
US (2) US20150174258A1 (da)
EP (1) EP2877156B1 (da)
CN (1) CN104684542A (da)
CA (1) CA2880012C (da)
CY (1) CY1122538T1 (da)
DK (1) DK2877156T3 (da)
ES (1) ES2765199T3 (da)
HK (1) HK1209334A1 (da)
HU (1) HUE048502T2 (da)
IT (1) ITMI20121316A1 (da)
PL (1) PL2877156T3 (da)
RU (1) RU2642612C2 (da)
WO (1) WO2014016380A1 (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105873713B (zh) * 2014-01-07 2018-07-10 株式会社村田制作所 结构材料接合方法、接合用片材和接合结构
CN108904449A (zh) * 2018-08-20 2018-11-30 广州云雾雾化应用技术研究院(普通合伙) 一种雾态软骨素在制备修复角膜的药物中的应用

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1188988A (en) * 1981-07-02 1985-06-18 Alan G. Walton Chondroitin drug complexes
CA1340994C (en) 1989-09-21 2000-05-16 Rudolf Edgar Dr. Falk Treatment of conditions and disease
US5639738A (en) 1992-02-20 1997-06-17 Hyal Pharmaceutical Corporation Treatment of basal cell carcinoma and actinic keratosis employing hyaluronic acid and NSAIDs
US5792753A (en) 1991-07-03 1998-08-11 Hyal Pharmaceutical Corporation Compositions comprising hyaluronic acid and prostaglandin-synthesis-inhibiting drugs
NZ322588A (en) * 1995-11-13 1999-01-28 Pitmy Int Nv An administration medium containing nitrous oxide for use in conjunction with analgesics, anti-inflammatories and anti-pyretics to enhance their action
IT1289613B1 (it) 1997-02-07 1998-10-15 Inalco Spa Polisaccaridi batterici o-solfatati
US6987023B2 (en) 1998-04-02 2006-01-17 The Board Of Regents Of The University Of Oklahoma DNA encoding hyaluronan synthase from Pasteurella multocida and methods of use
BR9909346A (pt) 1998-04-02 2001-09-11 Univ Oklahoma Segmento de ácido nucleico, vetor recombinante, célula hospedeira, composição, processos para detectar uma espécie de dna, uma célula bacteriana e infecção, para produzir ácido hialurÈnico e para criar uma vacina, sequência de ácido nucleico e de cdna, vacina e teste diagnóstico
US20030104601A1 (en) * 1999-04-01 2003-06-05 Deangelis Paul L. Chondroitin synthase gene and methods of making and using same
US6051587A (en) * 1998-04-16 2000-04-18 Medicure, Inc. Treatment of iatrogenic and age-related hypertension and pharmaceutical compositions useful therein
US6482401B1 (en) * 1998-12-23 2002-11-19 Naturopathic Laboratories International, Inc. Composition for the relief of joint pain and myofascial pain and method of preparing same
ITMI991465A1 (it) 1999-07-02 2001-01-02 Inalco Spa Processo per la preparazione dei polisaccaridi k4 e k5 da escherichiacoli
JP2004512013A (ja) 2000-04-25 2004-04-22 デ アンジェリス,ポール,エル. コンドロイチンシンターゼ遺伝子並びにその生成方法及び使用方法
EP1270015A3 (en) * 2001-06-29 2004-02-25 Sankyo Company Limited A complex comprising OCIF and Polysaccharide
JP4702819B2 (ja) 2001-08-01 2011-06-15 生化学工業株式会社 コンドロイチン合成酵素
JP4101548B2 (ja) 2001-08-10 2008-06-18 生化学工業株式会社 コンドロイチン合成酵素及びそれをコードするdna
ITMI20012200A1 (it) 2001-10-22 2003-04-22 Ibsa Inst Biochimique Sa Processo per la preparazione di condroitin solfati dal polisaccaride k4 e prodotti ottenuti
JP4171791B2 (ja) 2002-04-30 2008-10-29 独立行政法人産業技術総合研究所 糖転移作用剤
JP4333880B2 (ja) 2002-05-31 2009-09-16 生化学工業株式会社 コンドロイチン合成酵素および該酵素をコードするdna
US7232676B2 (en) 2002-05-31 2007-06-19 Seikagaku Kogyo Kabushiki Kaisha Chondroitin synthase and nucleic acid encoding the enzyme
FR2867981B1 (fr) * 2004-03-24 2008-10-31 Genevrier Sa Lab Utilisation des chondroitine mono-et disulfates en therapeutique
US7442682B2 (en) * 2004-10-19 2008-10-28 Nitto Denko Corporation Transepithelial delivery of peptides with incretin hormone activities
US8129148B2 (en) 2005-08-24 2012-03-06 Seikagaku Corporation Process for preparation of chondroitin fraction
WO2007058252A1 (ja) 2005-11-17 2007-05-24 Seikagaku Corporation コンドロイチンの製造方法
EP1964924B1 (en) 2005-12-15 2015-09-30 Seikagaku Corporation Long-chain chondroitin sugar chain and method for producing the same and method for promoting synthesis of chondroitin
US7927837B2 (en) 2006-06-12 2011-04-19 Seikagaku Corporation Modified chondroitin synthase polypeptide and crystal thereof
EP2106798A1 (en) * 2008-04-02 2009-10-07 Nestec S.A. Sulfated unsaturated disaccharidic chondroitin sulfate in connective tissue protection and repair
JP2010173990A (ja) * 2009-01-30 2010-08-12 Alpha-Nano-Medica Co Ltd 遺伝子治療剤
IT1394311B1 (it) 2009-05-25 2012-06-06 Altergon Sa Produzione biotecnologica di condroitina
WO2011109438A1 (en) 2010-03-01 2011-09-09 Martek Biosciences Corporation Compositions and methods for bacterial production of chondroitin
US20120094951A1 (en) * 2010-10-15 2012-04-19 Mark Robinson Compositions

Also Published As

Publication number Publication date
CA2880012A1 (en) 2014-01-30
US20190000803A1 (en) 2019-01-03
WO2014016380A1 (en) 2014-01-30
EP2877156A1 (en) 2015-06-03
EP2877156B1 (en) 2020-01-01
CA2880012C (en) 2021-05-04
RU2642612C2 (ru) 2018-01-25
HUE048502T2 (hu) 2020-07-28
US10675270B2 (en) 2020-06-09
ITMI20121316A1 (it) 2014-01-28
CY1122538T1 (el) 2021-01-27
HK1209334A1 (en) 2016-04-01
US20150174258A1 (en) 2015-06-25
ES2765199T3 (es) 2020-06-08
CN104684542A (zh) 2015-06-03
RU2015102000A (ru) 2016-09-20
PL2877156T3 (pl) 2020-07-27

Similar Documents

Publication Publication Date Title
CY2022027I2 (el) Παραγωγα βενζιμιδαζολο-προλινης
PT2878018T (pt) Resumo
DK3187586T3 (da) Inducerbar co-ekspressionssystem
EP2763896A4 (en) UNMANUFACTURED AIRCRAFT WITH SEVERAL ROTORS
DK2859055T3 (da) Polymercoatings
EP2807309A4 (en) ABFLUSSSIEB
PT2819623T (pt) Resumo
DK2825087T3 (da) Otoscanner
EP2809145A4 (en) CHLOROPLAST TRANSIT PEPTIDES
DK2839013T3 (da) Ikke-disruptiv-gen-targetering
EP2814472A4 (en) DITHIOAMINE REDUCING AGENTS
EP2824794A4 (en) Charging cable
EP2847405A4 (en) DOOR CLOSURE SYSTEM
EP2805877A4 (en) UNDER HOOD
DK2873977T3 (da) Dobbeltdækker-rørdispenser
DE112012006109A5 (de) Okklusionsschienenanordnung
DK2854722T3 (da) Stomipose
EP2815053A4 (en) GATE
PT2674413T (pt) Resumo
DE102013108016A8 (de) Sicherheitshülle
PT2831109T (pt) Resumo
PT2825212T (pt) Resumo
EP2831482A4 (en) Flange gasket
EP2816694A4 (en) FLAT CABLE WINDING DEVICE
DK2825157T3 (da) Aminosyrelipider